Gustavo Cancela e Penna Alterações moleculares na tumorigênese ...

REFERÊNCIAS BIBLIOGRÁFICAS:
Adeniran A, Zhu Z, Gandhi M, Steward D, Fidler J, Giordano T, Biddinger P,
Nikiforov Y. Correlation between genetic alterations and microscopic
features, clinical manifestations, and prognostic characteristics of thyroid
papillary carcinomas. Am J Surg Pathol 2006; 30: 216-222
Aqeilan R, Pekarsky Y, Herrero J, Palamarchuk A, Letofsky J, Druck T,
Trapasso F, Han S, Melino G, Huebner K, Croce C. Functional
association between WWOX tumor suppressor protein and p73, a p53
homolog. Proc Natl Acad Sci USA 2004; 101: 4401-4406
Aqeilan R, Trapasso F, Hussain S, Costinean S, Marshall D, Pekarsky Y,
Hagan J, Zanesi N, Kaou M, Stein G, Lian J, Croce C. Targeted deletion
of Wwox reveals a tumor suppressor function. Proc Natl Acad Sci USA
2007; 104: 3949-3954
Chang N, Doherty J, Ensing A, Schultz L, Hsu L, Hong Q. WOX1 is essential for
tumor necrosis factor-, UV Light-, Stauropsorine-, and p53 mediated cell
death, and its tyrosine 33-phosphorylated form binds and stabilizes
Serine 46-phosphorylated p53. J Biol Chem 2005; 280: 43100-43108
Ciampi R, Nikiforov Y. Minireview: RET/PTC Rearrangements and BRAF
mutations in thyroid tumorigenesis. Endocrinology 2007; 148:936-941
Connolly D, Greenspan R, Wu R, Ren X, Dunn R, Shah K. Loss of FHIT
expression in invasive cervical carcinomas and intraepithelial lesions
associated with invasive disease. Clin Cancer Res 2000; 6:3505-3510
37